Substandard, falsified meds focus

FIP has launched a new resource to help countries self-assess the adequacy of their regulatory systems to support pharmacy interventions to prevent the harms of substandard and falsified medicines Developed by the International Pharmaceutical Federation’s Regulators Advisory Group, it covers pharmacist-led roles and the responsibilities of ministries of health.  “FIP is seriously concerned about the ever-increasing risk